Insulin glulisine
APIDR_C_02083
Approved small_molecule completed
Quick answer
Insulin glulisine for Diabetes Mellitus, Type 1 is a Approved program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Diabetes Mellitus, Type 1
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed